At SPARSH Hospital, India, our Bone Marrow Transplant (BMT) Program offers comprehensive care for patients with blood disorders, hematologic malignancies, and immune deficiencies. Our multidisciplinary team of hematologists, transplant specialists, oncologists, and nursing staff provides state-of-the-art treatment, individualized care, and world-class post-transplant support for both domestic and international patients.

Using advanced protocols, sterile transplant units, and cutting-edge monitoring systems, SPARSH Hospital ensures high success rates and optimal patient outcomes for bone marrow and stem cell transplants in India.

Types of Bone Marrow Transplants

• Autologous BMT: Using the patient’s own stem cells
• Allogeneic BMT: Using stem cells from a matched donor (related or unrelated)
• Umbilical Cord Stem Cell Transplant: Using cord blood stem cells
• Haploidentical Transplant: Partial match transplant for patients without fully matched donors

Conditions Treated

• Leukemia (AML, ALL, CML)
• Lymphoma (Hodgkin’s & Non-Hodgkin’s)
• Aplastic anemia
• Multiple myeloma
• Myelodysplastic syndromes
• Congenital immune deficiencies
• Other hematologic and metabolic disorders

Why Choose SPARSH Hospital for BMT

• Internationally trained hematologists and transplant specialists
• Advanced stem cell and bone marrow transplant units
• Comprehensive pre-transplant evaluation and donor search
• State-of-the-art infection control and ICU facilities
• High success rates supported by evidence-based protocols
• Dedicated international patient support for travel, accommodation, and follow-up care

Transplant Process

• 1. Evaluation & Planning: Complete medical assessment of patient and donor
• 2. Conditioning Therapy: Chemotherapy and/or radiotherapy to prepare for transplant
• 3. Stem Cell Infusion: Transplant of harvested stem cells or bone marrow
• 4. Post-Transplant Care: ICU monitoring, infection prevention, and supportive therapy
• 5. Long-Term Follow-Up: Regular check-ups, immune monitoring, and rehabilitation

1. What is a bone marrow transplant?

Bone marrow transplant (BMT) involves replacing damaged or diseased bone marrow with healthy stem cells to restore blood cell production and immune function.

2. Are international patients eligible for BMT in India?

Yes. SPARSH Hospital provides complete support for international patients, including medical visa assistance, travel, accommodation, and treatment coordination.

3. What is the difference between autologous and allogeneic transplant?

• Autologous BMT: Uses the patient’s own stem cells
• Allogeneic BMT: Uses stem cells from a compatible donor (related or unrelated)

4. How long does hospitalization last after BMT?

Hospitalization varies depending on transplant type. Typically, 3–6 weeks are required for monitoring and recovery, followed by long-term follow-up.

5. What are the risks of BMT?

Risks include infection, graft-versus-host disease (for allogeneic transplants), bleeding, and other complications. Our team implements strict protocols to minimize risks.

6. How long before patients can return home after BMT?

Patients usually return home after initial stabilization (around 3–6 weeks) and continue remote follow-up with telemedicine support.

7. Is donor matching required?

Yes, careful donor matching is essential for allogeneic and haploidentical transplants to ensure compatibility and success.